We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

FRSH:NASDAQFreshworks Inc. Analysis

Data as of 2026-06-17 - not real-time

$9.50

Latest Price

7/10Risk

Risk Level: Medium

Executive Summary

Freshworks (FRSH) trades around $9.5, well below its DCF‑derived fair value of $27.6, implying roughly a 24% upside. The stock sits just above its 20‑day SMA ($9.42) and 50‑day SMA ($8.86), while the RSI is neutral at 55 and the MACD histogram is slightly negative, suggesting a modest short‑term bias but no strong momentum. Technical indicators point to a neutral trend with a solid support at $8.84 and resistance near $10.69, and volume is on an increasing trajectory, adding liquidity confidence. Fundamentally, FRSH delivers a high gross margin (~85%) and a healthy revenue growth rate of 16.5%, yet operating margin remains negative, though profit margin is positive at 20%. The balance sheet is strong, with $780 M cash against $38 M debt, and free cash flow exceeds $260 M, supporting the undervalued narrative. Recent material news includes a Zacks Rank 1 Strong Buy upgrade and the launch of an AI Agent Studio for Freshservice, both of which could catalyze near‑term demand, while a announced 500‑person reduction introduces a one‑time $8 M restructuring charge.
The valuation metrics—PE of 15.6 versus an industry average of 37, and a price‑to‑book of 2.6—underscore a fairly priced but still discounted position. However, the stock’s 30‑day volatility exceeds 50% and beta under 1 indicate heightened price swings typical for the software‑application sector. Given the mix of strong cash generation, growth prospects, and elevated risk, a nuanced stance across horizons is warranted.

Market Outlook

Short Term

< 1 year
Positive
Model confidence: 7/10

Key Factors

  • Zacks Rank 1 Strong Buy upgrade
  • Price above short‑term moving averages
  • Support level near $8.84 providing downside cushion

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Undervalued relative to DCF and industry PE
  • Revenue growth of 16.5% with high gross margins
  • Robust cash position and positive free cash flow

Long Term

> 3 years
Neutral
Model confidence: 6/10

Key Factors

  • Operating margin remains negative despite profit margin
  • Restructuring charge and workforce reduction
  • Long‑term AI product rollout and competitive SaaS landscape

Key Metrics & Analysis

Financial Health

Revenue Growth16.50%
Profit Margin20.69%
P/E Ratio15.6
ROE17.32%
ROA0.62%
Debt/Equity3.81
P/B Ratio2.6
Op. Cash Flow$246.8M
Free Cash Flow$263.7M
Industry P/E37.2

Technical Analysis

TrendNeutral
RSI55.0
Support$8.84
Resistance$10.69
MA 20$9.42
MA 50$8.86
MA 200$10.34
MACDBearish
VolumeIncreasing
Fear & Greed Index92.23

Valuation

Fair Value$27.60
Target Price$11.75
Upside/Downside23.68%
GradeUndervalued
TypeBlend

Risk Assessment

Beta0.80
Volatility52.59%
Sector RiskHigh
Reg. RiskMedium
Geo RiskMedium
Currency RiskMedium
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.